Device, system, and method for transcatheter treatment of valve regurgitation
The invention relates to a device for use in the transcatheter treatment of mitral valve regurgitation, specifically a coaptation enhancement element for implantation across the valve; a system including the coaptation enhancement element and anchors for implantation; a system including the coaptation enhancement element, catheter and driver; and a method for transcatheter implantation of a coaptation element across a heart valve.
1. A coaptation implant comprising:
a coaptation surface configured for an anterior leaflet of a valve to coapt against;
a superior edge, lateral edges, and an inferior edge, wherein the superior edge has a length greater than a length of the inferior edge, such that a transverse distance between lateral edges generally decreases from the superior edge to the inferior edge of the coaptation implant;
wherein an annular curve radius of the coaptation implant is a measurement defining a curvature of the superior edge of the coaptation implant, and
wherein an overall element arc length of the coaptation implant is a measurement from the superior edge to the inferior edge of the coaptation implant measured along an anterior surface of the coaptation implant.
2. The coaptation implant of claim 1 , wherein the inferior edge length is in the range of 1-15 mm.
3. The coaptation implant of claim 1 , wherein the annular curve radius is in the range of 15-50 mm.
4. The coaptation implant of claim 1 , wherein the overall element arc length is in the range of 25-100 mm.
5. The coaptation implant of claim 1 , wherein a coaptation element length corresponds to the distance between a most proximal level of the coaptation implant and a ventricular anchor site as measured perpendicular to a plane defined by an annulus of the valve; and a ventricular element length corresponds to the distance between a level of the valve and the ventricular anchor site as measured perpendicular to the plane defined by the annulus of the valve, wherein an element length ratio of the ventricular element length to the coaption element length is less than about 0.9.
6. The coaptation implant of claim 1 , further comprising an annular anchor site.
7. The coaptation implant of claim 1 , wherein the geometry of the coaptation implant is configured to conform substantially to a portion of the surface of a cone.
8. The coaptation implant of claim 1 , wherein the shape of the coaptation implant is configured to conform substantially to a portion of the surface of a cone for about 50% to about 70% of a total height measured along the longitudinal axis of the cone, and then the shape of the coaptation implant extends radially outwardly from the cone to form a radially outward flare.
9. The coaptation implant of claim 8 , wherein the radially outward flare has a radius within a range of from about 5 mm to about 12 mm.
10. The coaptation implant of claim 1 , further comprising at least one strut disposed within a covering material for maintenance of a shape of the coaptation implant.
11. The coaptation implant of claim 10 , wherein the at least one strut is composed of resiliently deformable materials or a Nitinol alloy.
12. The coaptation implant of claim 10 , wherein the at least one strut is stiffer at an annular end than at a ventricular end of the coaptation implant.
13. The coaptation implant of claim 10 , wherein the anterior surface and a posterior surface of the coaptation implant further comprise a covering comprised of ePTFE, polyurethane foam, polycarbonate foam, biologic tissue, porcine pericardium, or silicone.
14. The coaptation implant of claim 10 , wherein a plurality of struts assists in maintaining a distance between lateral margins of the superior edge.